Botulinum toxin A in the early treatment of sixth nerve palsy in type 2 diabetes.
Ganesh S, Anilkumar SE, Narendran K.
Indian J Ophthalmol. 2019 Jul;67(7):1133-1136. doi: 10.4103/ijo.IJO_1267_18.
PMID:31238428
Malignant Otitis External: Our Experience and Literature Review.
Di Lullo AM, Russo C, Piroli P, Petti A, Capriglione P, Cantone E, Motta G, Iengo M, Elefante A, Cavaliere M.
Am J Case Rep. 2020 Aug 18;21:e925060. doi: 10.12659/AJCR.925060.
PMID:32808601
[A case of slowly progressive type 1 diabetes mellitus developing myeloperoxidase-specific anti-neutrophil cytoplasmic antibody-associated vasculitis with hypertrophic pachymeningitis manifesting as multiple cranial nerve palsy].
Kurihara Y, Oku K, Suzuki A, Ohsone Y, Handa M, Okano Y.
Retrospective Analysis of Factors Related to the Long-Term Recovery of Third, Fourth, and Sixth Cranial Nerve Palsy with Etiologies and Clinical Course in a Tertiary Hospital.
Srimanan W, Panyakorn S.
Clin Ophthalmol. 2024 Feb 9;18:441-450. doi: 10.2147/OPTH.S449127. eCollection 2024.
PMID:38352051
Risk of ischemic stroke after third, fourth, and sixth cranial nerve palsies in type 2 diabetes.
Park SJ, Yang HK, Byun SJ, Park KH, Hwang JM.
J Diabetes. 2019 May;11(5):379-385. doi: 10.1111/1753-0407.12859. Epub 2018 Nov 15.
PMID:30251398
Temporary multiple cranial nerve palsies in a patient with type 1 diabetes mellitus.